Is PAX Labs profitable in 2026?

PAX Labs does not publicly disclose audited financials. A third-party vendor (PrivCo) estimated 2024 revenue at roughly $380M, but no profitability figures have been confirmed by the company itself as of July 2026.

PAX Labs is privately held and venture-backed, last valued at $1.7 billion after a $420 million round in April 2019. Investors include Fidelity Investments, Tiger Global, Tao Invest, Evolution VC Partners, and Redmile Group. No IPO or acquisition has occurred.

Is PAX Labs losing to Stiiizy?

PAX won an ITC import ban against Stiiizy on January 20, 2026, but by July 14, 2026, U.S. Customs and Border Protection issued a third ruling that Stiiizy's redesigned products (V3, batteries/pods, new AIO) do not infringe PAX patents.

Could AI replace PAX Labs' products?

No evidence shows PAX Labs deploying generative AI in its vaporizer hardware or apps as of July 2026. Its core value chain, physical hardware, cannabis-oil supply deals, and dispensary distribution, remains largely unaffected by frontier AI.

What is PAX Labs' biggest competitor?

Stiiizy is PAX's most direct threat, having overcome a January 2026 ITC import ban via product redesigns cleared by CBP three times by July 2026. Storz & Bickel, owned by Canopy Growth, is cited as the premium dry-herb benchmark.

When did PAX Labs last raise funding?

PAX Labs' last priced equity round was in April 2019, a $420 million raise valuing the company at $1.7 billion. No new priced valuation has been reported since, despite a private secondary trade recorded in February 2023.

United States · United States

PAX

PAX Labs makes premium vaporizers for cannabis flower and concentrate.

Losing its protection

Assessed 29 July 2026 · Evidence as of 29 July 2026

The structural protection is eroding.

On the recordSince 29 July 2026 · Checkable from within 6-12 months · Every call on the record Checkpoint: Appellate ruling or further CBP decision on Stiiizy/ALD patent redesign dispute

The call

PAX still leads on brand and patents, but Customs just let a rival design around its main legal barrier while its valuation sits unchanged for seven years.

PAX Labs designs and sells vaporizers for cannabis products. The company long relied on two shields: federal cannabis illegality kept big electronics companies out of the market, and PAX's patents stopped competitors like Stiiizy from copying its designs. Both shields are now failing. In 2026, Stiiizy redesigned its products and got U.S. Customs approval anyway, punching a hole in PAX's patent protection. Meanwhile, PAX has not released audited financial statements in seven years, so no one can verify if the company's claimed $1.7 billion value from 2019 is real or inflated. The one thing that could change the outlook is whether PAX can win new patent cases against Stiiizy or land fresh investment with transparent numbers, but neither looks likely right now.

Why

AI pressure: None apparent. Hardware vaping devices sit outside software/AI disruption; no AI product substitutes for the physical device. Could AI do the core job? Unlikely.

Bigger players: Stiiizy. Stiiizy redesigned its pod hardware and got US Customs to clear it as non-infringing, undoing PAX's ITC import ban win from six months earlier. Could a giant copy it? Probably.

What protects it. Federal cannabis illegality keeps big consumer-electronics and CPG giants out of the category entirely, protecting PAX and its rivals alike.

What would change this call

CBP or appellate ruling on Stiiizy's redesigned products. Shows whether PAX's patent moat still excludes rivals or is exhausted.
A new priced funding round for PAX at, above, or below the 2019 $1.7B mark. Validates or invalidates PAX's long-standing valuation.
Federal cannabis rescheduling or SAFE Banking Act passage. Would open the category to big consumer-goods entrants, eroding PAX's regulatory protection.

Key numbers

Last priced valuation $1.7B (2019-04-01)
Total funding raised approximately $504.2M (2026-02-28)
25% layoff, 65 workers cut (2019-10-21)

Named risks

Patent moat undermined by three CBP rulings clearing Stiiizy redesigns as of July 2026. Severity: high
Valuation frozen at $1.7B since April 2019 with no new priced round in seven years. Severity: high
Conflicting headcount data (70 vs 350 vs 201-500) signals unclear organizational stability. Severity: medium
Federal cannabis illegality both protects and threatens PAX; legalization could remove its structural shield. Severity: medium
Rising cannabis-sector litigation (e.g., inflated THC potency suits) could extend liability to device makers. Severity: low

Rivals, as read in July 2026

Rival	Direction	Evidence
Stiiizy	gaining on	CBP ruled 3 times by 2026-07-14 that Stiiizy's redesigned products don't infringe PAX patents
Storz & Bickel	contesting	PAX launched PAX Four on 2026-03-03 explicitly positioned against Storz & Bickel's Mighty+
Puffco	contesting	Named as a direct peer in fragmented premium vaporizer market per 2026 industry reports
DaVinci	contesting	Cited alongside PAX as competing premium vaporizer maker in Pitchbook 2026 profile

Questions people ask

Is PAX Labs profitable in 2026?: PAX Labs does not publicly disclose audited financials. A third-party vendor (PrivCo) estimated 2024 revenue at roughly $380M, but no profitability figures have been confirmed by the company itself as of July 2026.
Who owns PAX Labs?: PAX Labs is privately held and venture-backed, last valued at $1.7 billion after a $420 million round in April 2019. Investors include Fidelity Investments, Tiger Global, Tao Invest, Evolution VC Partners, and Redmile Group. No IPO or acquisition has occurred.
Is PAX Labs losing to Stiiizy?: PAX won an ITC import ban against Stiiizy on January 20, 2026, but by July 14, 2026, U.S. Customs and Border Protection issued a third ruling that Stiiizy's redesigned products (V3, batteries/pods, new AIO) do not infringe PAX patents.
Could AI replace PAX Labs' products?: No evidence shows PAX Labs deploying generative AI in its vaporizer hardware or apps as of July 2026. Its core value chain, physical hardware, cannabis-oil supply deals, and dispensary distribution, remains largely unaffected by frontier AI.
What is PAX Labs' biggest competitor?: Stiiizy is PAX's most direct threat, having overcome a January 2026 ITC import ban via product redesigns cleared by CBP three times by July 2026. Storz & Bickel, owned by Canopy Growth, is cited as the premium dry-herb benchmark.
When did PAX Labs last raise funding?: PAX Labs' last priced equity round was in April 2019, a $420 million raise valuing the company at $1.7 billion. No new priced valuation has been reported since, despite a private secondary trade recorded in February 2023.

Timeline

2026-07-14CBP issues third ruling that Stiiizy's redesigned products do not infringe PAX patents
2026-03-03PAX launches PAX Four hybrid-heating portable priced at $250
2026-01-20PAX wins ITC Section 337 import exclusion order against Stiiizy and ALD
2025-08-01PAX launches PAX Flow (hybrid heating, USB-C) and PAX Mini 2
2023-07-01PAX launches My PAX device-personalization platform
2023-02-01Private secondary transaction of PAX Labs stock recorded, no new valuation set
2019-10-21PAX Labs lays off 25% of staff (65 workers) after missing revenue projections
2019-04-01PAX Labs raises $420M at $1.7B valuation, its last priced round
2017-01-01PAX Labs spins out Juul Labs as a separate company

Revision history

29 July 2026

First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.

In the same band

American Airlines Group Wayfair Safe Superintelligence Inc.